Abstract:Motivation: Virtual screening of molecular compound libraries is a potentially powerful and inexpensive method for the discovery of novel lead compounds for drug development. The major weakness of virtual screening-the inability to consistently identify true positives (leads)-is likely due to our incomplete understanding of the chemistry involved in ligand binding and the subsequently imprecise scoring algorithms. It has been demonstrated that combining multiple scoring functions (consensus scoring) improves the enrichment of true positives. Previous efforts at consensus scoring have largely focused on empirical results, but they have yet to provide a theoretical analysis that gives insight into real features of combinations and data fusion for virtual screening. Results: We demonstrate that combining multiple scoring functions improves the enrichment of true positives only if (a) each of the individual scoring functions has relatively high performance and (b) the individual scoring functions are distinctive. Notably, these two prediction variables are previously established criteria for the performance of data fusion approaches using either rank or score combinations. This work, thus, establishes a potential theoretical basis for the probable success of data fusion approaches to improve yields in in silico screening experiments. Furthermore, it is similarly established that the second criterion (b) can, in at least some cases, be functionally defined as the area between the rank versus score plots generated by the two (or more) algorithms. Because rank-score plots are independent of the performance of the individual scoring function, this establishes a second theoretically defined approach to determining the likely success of combining data from different predictive algorithms. This approach is, thus, useful in practical settings in the virtual screening process when the performance of at least two individual scoring functions (such as in criterion a) can be estimated as having a high likelihood of having high performance, even if no training sets are available. We provide initial validation of this theoretical approach using data from five scoring systems with two evolutionary docking algorithms on four targets, thymidine kinase, human dihydrofolate reductase, and estrogen receptors of antagonists and agonists. Our procedure is computationally efficient, able to adapt to different situations, and scalable to a large number of compounds as well as to a greater number of combinations. Results of the experiment show a fairly significant improvement (vs single algorithms) in several measures of scoring quality, specifically "goodness-of-hit" scores, false positive rates, and "enrichment". This approach (available online at http://gemdock.life. nctu.edu.tw/dock/download.php) has practical utility for cases where the basic tools are known or believed to be generally applicable, but where specific training sets are absent.

Convolutional Neural Network-based Virtual Screening

Convolutional Neural Network Based Virtual Screening.

A Case-Based Meta-Learning Algorithm Boosts the Performance of Structure-Based Virtual Screening.

Protein-Ligand Scoring with Convolutional Neural Networks

Deep Learning in Virtual Screening: Recent Applications and Developments

Validation of Deep Learning-Based DFCNN in Extremely Large-Scale Virtual Screening and Application in Trypsin I Protease Inhibitor Discovery

DENVIS: Scalable and High-Throughput Virtual Screening Using Graph Neural Networks with Atomic and Surface Protein Pocket Features

Virtual Screening of Molecules via Neural Fingerprint-based Deep Learning Technique

Consensus scoring criteria for improving enrichment in virtual screening

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

Deep Learning and Virtual Drug Screening

Visualizing convolutional neural network protein-ligand scoring

Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries.

Consensus holistic virtual screening for drug discovery: a novel machine learning model approach

RealVS: Toward Enhancing the Precision of Top Hits in Ligand-Based Virtual Screening of Drug Leads from Large Compound Databases

Advancing Ligand Docking through Deep Learning: Challenges and Prospects in Virtual Screening

An artificial intelligence accelerated virtual screening platform for drug discovery

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

PharmacoNet: deep learning-guided pharmacophore modeling for ultra-large-scale virtual screening

Recent Development and Application of Virtual Screening in Drug Discovery: An Overview